BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 3
• 4
• 5
• 6
• 7
• 10
• 11
• 12
• 13
• 14
• 15
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28
• 31

• Business

  Quintiles, Inc. Speeds Early-Phase Decision Making with New Unit in Hyderabad, India

  January 24, 2011

   · 

  1 min read
• Drug Development

  Furiex Pharmaceuticals, Inc. Receives FDA Fast Track Designation of MuDelta for the Treatment of Diarrhea-Predominant Irritable Bowel Syndrome

  January 24, 2011

   · 

  1 min read
• Biotech Bay

  Biomagnetics Diagnostics Corporation Completes Q3:10 Audit – Provides Recap of Recently Held Conference Call

  January 24, 2011

   · 

  1 min read
• Business

  TetraPhase Pharmaceuticals Appoints Patrick Horn, M.D., Ph.D., as Chief Medical Officer

  January 24, 2011

   · 

  1 min read
• Pharm Country

  Senesco Technologies, Inc. Announces IND Filing with FDA for SNS01-T

  January 24, 2011

   · 

  1 min read
• Cerbomed: A New Study Proves the Painkilling Effect of Transcutaneous Vagus Nerve Stimulation at Man

  January 24, 2011

   · 

  1 min read
• BioCapital

  Celsion Corporation Announces Completion of $5.1 Million Registered Direct Offering

  January 24, 2011

   · 

  3 min read
• Policy

  MEDA Receives Positive Opinion for Retigabine in Europe

  January 24, 2011

   · 

  1 min read
• BioCapital

  Octapharma USA, Inc. Supports NHIA Educational Program for the Diagnosis and Management of von Willebrand Disease

  January 24, 2011

   · 

  3 min read
• Drug Development

  British Journal of Psychiatry Publishes Results from Phase 3 Study of Alexza Pharmaceuticals, Inc.'s AZ-004 for the Treatment of Agitation in Patients with Schizophrenia

  January 24, 2011

   · 

  6 min read